Nancy Pelosi has disclosed a major update to her investment portfolio, revealing more than $10 million in cumulative stock ...
Blue-chip tech stocks are a big part of President Donald Trump's portfolio, according to his latest financial disclosures.
Baker Brothers’ Q3 2025 13F portfolio rose to $13.84B, with high concentration in BeOne Medicines, Incyte, Madrigal Pharma, Insmed, and ACADIA Pharma. INCY, now ~19% of the portfolio, saw a marginal ...
Fairholme's 13F portfolio remains highly concentrated, with ~78% allocated to St. Joe Company, reflecting a long-term conviction position. Portfolio value held steady at ~$1.24B in Q3 2025, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results